scholarly journals Promise of Wearable Physical Activity Monitors in Oncology Practice

2017 ◽  
Vol 13 (2) ◽  
pp. 82-89 ◽  
Author(s):  
Muhammad S. Beg ◽  
Arjun Gupta ◽  
Tyler Stewart ◽  
Chad D. Rethorst
Keyword(s):  
Physical Activity ◽  
Relevant Information ◽  
Activity Monitoring ◽  
Chronic Obstructive ◽  
Oncology Patient ◽  
Activity Monitors ◽  
Patients With Cancer ◽  
Physical Activity Monitoring ◽  
Physical Activity Monitors ◽  
Oncology Practice

Commercially available physical activity monitors provide clinicians an opportunity to obtain oncology patient health measures to an unprecedented degree. These devices can provide objective and quantifiable measures of physical activity, which are not subject to errors or bias of self-reporting or shorter duration of formal testing. Prior work on so-called quantified-self data was based on older-generation, research-grade accelerometers, which laid the foundation for consumer-based physical activity monitoring devices to be validated as a feasible and reliable tool in patients with cancer. Physical activity monitors are being used in chronic conditions including chronic obstructive pulmonary disease, congestive heart failure, diabetes mellitus, and obesity. Differing demographics, compounded with higher symptom and treatment burdens in patients with cancer, imply that additional work is needed to understand the unique strengths and weaknesses of physical activity monitors in this population. Oncology programs can systematically implement these tools into their workflows in an adaptable and iterative manner. Translating large amounts of data collected from an individual physical activity monitoring device into clinically relevant information requires sophisticated data compilation and reduction. In this article, we summarize the characteristics of older- and newer-generation physical activity monitors, review the validation of physical activity monitors with respect to health-related quality-of-life assessments, and describe the current role of these devices for the practicing oncologist. We also highlight the challenges and next steps needed for physical activity monitors to provide relevant information that can change the current state of oncology practice.

scholarly journals Physical Activity Monitoring Preferences in Adults With Bipolar Disorder

2021 ◽  
Vol 12 ◽  
Author(s):  
Carol A. Janney ◽  
Abigail R. Ducheine ◽  
Robert Reichmann ◽  
Matthew A. Stack ◽  
Andrea Fagiolini
Keyword(s):  
Physical Activity ◽  
Bipolar Disorder ◽  
Large Scale ◽  
Secondary Data ◽  
Activity Monitor ◽  
Activity Monitoring ◽  
Psychiatric Institute ◽  
Activity Monitors ◽  
Physical Activity Monitoring ◽  
Caucasian Women

This report investigated physical activity (PA) monitoring preferences and problems among adults with bipolar disorder (BD).Methods: PARC2 study was conducted at the Western Psychiatric Institute and Clinic at the University of Pittsburgh. This secondary data analysis assessed three PA monitors; Body Media SW Pro Armband, Actigraph AM-7164, and Pedometer Omron HJ-720IT. PA monitors were worn simultaneously for 1 week. Participants reported preferences and problems (irritating, cumbersome, movement of the activity monitor, technical difficulties, and impaired functioning) encountered with each activity monitor.Results: Approximately 70% of the participants (n = 66) were middle-aged Caucasian women with a diagnosis of BD I and overweight. Sixty-six adults with BD wore all 3 monitors simultaneously. Twelve (18%) participants had no PA monitoring preference, 28 (42%) preferred the armband, 17 (26%) preferred the pedometer and 9 (14%) preferred the Actigraph. Activity monitoring preferences did not statistically differ by age, gender, race, BMI, diagnosis, or depressive and mania symptoms (p > 0.25). Two-thirds of the participants (64%) had at least one problem with at least one activity monitor. As far as problem categories, more than a quarter of participants reported irritation with the Armband (26%, n = 17) and movement of the pedometer (32%, n = 21). No statistically significant association was observed between activity monitoring preferences and problems (p = 0.72).Discussion: Adults with BD were willing to wear activity monitors even though problems were reported. Preference of physical activity monitors, in descending order, was the armband, pedometer, and Actigraph. One fifth of the adults with BD reported no preferences in activity monitors. The activity monitors selected for investigation included the “gold standard” in activity monitoring (Actigraph) worn at the waist as well as a research grade pedometer that is considerably more affordable, provides activity feedback in real-time, and may be a more feasible option for large scale studies.

scholarly journals Validity and Usability of Physical Activity Monitoring in Patients with Chronic Obstructive Pulmonary Disease (COPD)

PLoS ONE ◽  
2016 ◽  
Vol 11 (6) ◽  
pp. e0157229 ◽  
Author(s):  
Tobias Boeselt ◽  
Marc Spielmanns ◽  
Christoph Nell ◽  
Jan Hendrik Storre ◽  
Wolfram Windisch ◽  
...  
Keyword(s):  
Physical Activity ◽  
Chronic Obstructive Pulmonary Disease ◽  
Pulmonary Disease ◽  
Activity Monitoring ◽  
Chronic Obstructive ◽  
Obstructive Pulmonary Disease ◽  
Physical Activity Monitoring

scholarly journals Wearables for Promoting Physical Activity

2018 ◽  
Vol 64 (1) ◽  
pp. 53-63 ◽  
Author(s):  
Scott J Strath ◽  
Taylor W Rowley
Keyword(s):  
Physical Activity ◽  
Rapid Expansion ◽  
Chronic Obstructive ◽  
Long Term Effects ◽  
Obstructive Pulmonary Disease ◽  
Activity Monitors ◽  
Physical Activity Monitors ◽  
Review Reports ◽  
Study Designs ◽  
Future Work

Abstract BACKGROUND The rapid expansion and popularity of consumer-wearable physical activity monitors (WPAMs) has enabled the integration of technology into physical activity (PA) intervention, deployment, and evaluation. This brief review reports on the accuracy of consumer-WPAMs, considers the intervention effects of using consumer-WPAMs, and offers future considerations as the proliferation of this area of product development and consumer use continues to escalate. CONTENT The studies reviewed document the utility for consumer-WPAMs to objectively assess PA, with output metrics similar to research-grade activity monitors. Early intervention efficacy for the use of consumer-WPAMs to increase PA holds considerable promise. Substantial increases in moderate- to vigorous-intensity PA (MVPA) have been reported across different research study designs and populations in which consumer-WPAMs have been used in isolation or in conjunction with other behavioral change strategies. The utility of consumer-WPAMs is currently being investigated in clinical populations, notably showing increases in PA in individuals at risk for cancer or post cancer survivors, in those with chronic obstructive pulmonary disease, and in postsurgical patients. There has been a proliferation of registered trials at clinicaltrials.gov, and an increase of disseminated works regarding the use of consumer-WPAMs is expected. SUMMARY There are many research studies documenting the validity and intervention effectiveness of consumer-WPAMs; evidence is emerging on the health benefits linked to use of such devices. Future work on the long-term effects of consumer-WPAMs on behavior and health is warranted, and prospects appear exciting as wearable technology advances and adoption increases.

scholarly journals Feasibility of Wearable Physical Activity Monitors in Patients With Cancer

2018 ◽  
pp. 1-10 ◽  
Author(s):  
Arjun Gupta ◽  
Tyler Stewart ◽  
Nizar Bhulani ◽  
Ying Dong ◽  
Zain Rahimi ◽  
...  
Keyword(s):  
Physical Activity ◽  
Systemic Therapy ◽  
Performance Status ◽  
Pilot Trial ◽  
Eastern Cooperative Oncology Group ◽  
Activity Monitors ◽  
Patients With Cancer ◽  
Steps Per Day ◽  
Physical Activity Monitors ◽  
Ecog Ps

Purpose The feasibility of using physical activity monitors (PAMs) to measure functional status in patients with cancer is unclear. We aimed to determine the feasibility of using PAMs to longitudinally assess physical activity and performance status (PS) in patients with cancer. Methods Patients with cancer who had Eastern Cooperative Oncology Group (ECOG) PS of 0 to 2 and were receiving systemic therapy were enrolled in a prospective pilot trial of PAM use. Feasibility was defined as patients using the PAM for > 50% of the observation period. We correlated PAM-reported measures with scores from ECOG PS and quality-of-life tools (Functional Assessment of Cancer Therapy–General [FACT-G], Quick Inventory of Depressive Symptoms–Self-Rated 16 [QIDS-SR16], and Brief Fatigue Inventory [BFI]) using Pearson’s correlation test. Patients were surveyed regarding their experience with PAMs at study completion. Results In all, 24 patients were enrolled; mean age was 54 years, 16 (67%) were women, and 19 (79%) were white. Twenty-three patients (96%) met the primary end point of feasibility. The median duration of follow-up was 69 days. Mean PAM-measured steps for ECOG PS of 0, 1, and 2 were 5,911, 1,890, and 845 steps per day, respectively ( P = .002). Minimum steps per day correlated with BFI ( r = –0.53; P < .01), FACT-G ( r = 0.45; P = .02), and QIDS-SR16 ( r = –0.57; P < .01). Eighteen patients (75%) reported a positive experience with the PAM. Conclusion PAMs are a feasible tool for measuring long-term physical activity in patients with cancer who are receiving systemic therapy. PAM-derived measures correlated with clinician-assessed PS.

Reliability, Validity and Responsiveness of Physical Activity Monitors in Patients with Inflammatory Myopathy

Rheumatology ◽  
2021 ◽  
Author(s):  
Bonny Rockette-Wagner ◽  
Didem Saygin ◽  
Siamak Moghadam-Kia ◽  
Chester Oddis ◽  
Océane Landon-Cardinal ◽  
...  
Keyword(s):  
Physical Activity ◽  
Construct Validity ◽  
Disease Activity ◽  
Retest Reliability ◽  
Activity Monitors ◽  
Muscle Testing ◽  
Patient Reported ◽  
Physical Activity Monitors ◽  
Global Disease Activity ◽  
Test Retest Reliability

Abstract Objective Idiopathic inflammatory myopathies (IIM) cause proximal muscle weakness, which affect activities of daily living. Wearable physical activity monitors (PAMs) objectively assess continuous activity with potential clinical usefulness in IIM assessment. We examined the psychometric characteristics for PAM outcomes in IIM. Methods Adult IIM patients were prospectively evaluated (baseline, 3 and 6-months) in an observational study. A waist-worn PAM (ActiGraph GT3X-BT) assessed average step counts/min, peak 1-min cadence, and vector magnitude/min. Validated myositis core set measures (CSM) including manual muscle testing (MMT), physician global disease activity (MD global), patient global disease activity (Pt global), extra-muscular disease activity (Ex-muscular global), HAQ-DI, muscle enzymes, and patient-reported physical function were evaluated. Test-retest reliability, construct validity, and responsiveness were determined for PAM measures and CSM using Pearson correlations and other appropriate analyses. Results 50 adult IIM patients enrolled [mean (SD) age, 53.6 (±14.6); 60% female, 94% Caucasian]. PAM measures showed strong test-retest reliability, moderate-to-strong correlations at baseline with MD global (r=-0.37- -0.48), Pt-global (r=-0.43- -0.61), HAQ-DI (r=-0.47- -0.59) and MMT (r = 0.37–0.52), and strong discriminant validity for categorical MMT and HAQ-DI. Longitudinal association with MD global (r=-0.38- -0.44), MMT (r = 0.50–0.57), HAQ-DI (r=-0.45- -0.55), and functional tests (r = 0.30–0.65) were moderate-to-strong. PAM measures were responsive to MMT improvement (≥10%) and moderate-to-major improvement on ACR/EULAR myositis response criteria. Peak 1-min cadence had the largest effect size and Standardized Response Means (SRMs). Conclusion PAM measures showed promising construct validity, reliability, and longitudinal responsiveness; especially peak 1-min cadence. PAMs provide valid outcome measures for future use in IIM clinical trials.

scholarly journals 2253

2017 ◽  
Vol 1 (S1) ◽  
pp. 40-41
Author(s):  
Stephen P. Wright ◽  
Kathryn Sandberg
Keyword(s):  
Physical Activity ◽  
Biomedical Research ◽  
Potential Growth ◽  
Activity Monitors ◽  
Ovid Medline ◽  
Physical Activity Monitors ◽  
Study Population ◽  
Health And Disease ◽  
Category Condition ◽  
Study Type

OBJECTIVES/SPECIFIC AIMS: To analyze how consumer physical activity monitors are currently used in biomedical research. METHODS/STUDY POPULATION: Searches were conducted in Ovid Medline, PubMed Medline, clinicaltrials.gov, and NIH RePORTER using search terms including Fitbit, Jawbone, Apple watch, Garmin, Polar, Microsoft band, Misfit, Nike, Withings, and Xiaomi. Results were quantitated by category: condition/topic, intervention, enrollment status, study type and design, age, grant mechanism, and primary outcome. RESULTS/ANTICIPATED RESULTS: Fitbit is used >80%. There are 127 clinical studies using Fitbit devices listed in clinicaltrials.gov. In total, 48 have been completed while 79 are ongoing. Some studies have already published their findings; 40 papers cited in Ovid MEDLINE report use of a Fitbit device. NIH is now funding research that uses consumer physical activity monitors, and the NIH RePORTER shows the number of grants using Fitbit is rapidly increasing. DISCUSSION/SIGNIFICANCE OF IMPACT: The current state and potential growth of this technology is transforming biomedical research and is enabling us to ask new and more granular questions about activity and sleep in health and disease.

Sign in / Sign up

Export Citation Format

Share Document